Cilnidipine is a third-generation calcium channel blocker that inhibits both L-type and N-type calcium channels.
It:
Its dual action allows stable blood pressure control with reduced reflex tachycardia.
Clinical studies demonstrate effective reduction of systolic and diastolic blood pressure.
By blocking N-type calcium channels, cilnidipine reduces sympathetic nerve activity, lowering the incidence of reflex tachycardia.
Evidence also suggests potential renoprotective benefits in hypertensive patients with diabetic nephropathy.
The medication reduces vascular tone and stabilizes blood pressure levels.
Take orally once daily or as directed by a healthcare provider. Swallow with water. Dosage and duration are determined individually.
Contraindications
Side effects
